Erasca (ERAS) Institutional Ownership
13F filers reported holding 82.4% of Erasca (ERAS) shares as of Jun 30, 2026, across 258 filers.
4 figures withheld by our checks. Each blank figure names its reason.
- Held by 13F filers
- 82.4%
- Jun 30, 2026
- 13F filers
- 258
- quarter ended Jun 30, 2026
- 13F value
- $5.3B
- 289.1M shares
Is the smart money (institutions and insiders) accumulating or distributing? One lagging input, not a buy signal.
| Date | Name | Role | Type | Shares | Price** | SEC filing |
|---|---|---|---|---|---|---|
| Aug 10, 2026 | Fuchs Charles S. | President, R&D | Acquired · Grant / award | 1,300,000Stock option (right to buy) | — | ↗ |
| Jun 26, 2026 | Start Valerie Denise Harding | director | Acquired · Grant / award | 29,888Stock option (right to buy) | — | ↗ |
| Jun 26, 2026 | LIU JEAN I | director | Acquired · Grant / award | 29,888Stock option (right to buy) | — | ↗ |
| Jun 26, 2026 | Multani Pratik S | director | Acquired · Grant / award | 29,888Stock option (right to buy) | — | ↗ |
| Jun 26, 2026 | Casdin Alexander W. | director | Acquired · Grant / award | 29,888Stock option (right to buy) | — | ↗ |
| Jun 26, 2026 | Hambleton Julie | director | Acquired · Grant / award | 29,888Stock option (right to buy) | — | ↗ |
| Jun 26, 2026 | Bristol James Arthur | director | Acquired · Grant / award | 29,888Stock option (right to buy) | — | ↗ |
| Apr 1, 2026 | Garner Ebun | Chief Legal Officer | Acquired · Option exercise | 80,000 | $1.70 | ↗ |
| Apr 1, 2026 | Garner Ebun | Chief Legal Officer | Disposed · Open-market sale | 80,000 | $16.40 | ↗ |
| Apr 1, 2026 | Garner Ebun | Chief Legal Officer | Disposed · Option exercise | 80,000Stock Option (right to buy) | — | ↗ |
| Mar 4, 2026 | Morris Shannon | Chief Medical Officer | Acquired · Option exercise | 20,000 | $1.70 | ↗ |
| Mar 4, 2026 | Morris Shannon | Chief Medical Officer | Disposed · Open-market sale | 20,000 | $15.04 | ↗ |
| Jan 29, 2026 | Lim Jonathan E | Chairman & CEO | Acquired · Grant / award | 2,000,000Stock option (right to buy) | — | ↗ |
| Jan 29, 2026 | Chacko David M. | CFO and CBO | Acquired · Grant / award | 640,000Stock option (right to buy) | — | ↗ |
| Jan 29, 2026 | Morris Shannon | Chief Medical Officer | Acquired · Grant / award | 625,000Stock option (right to buy) | — | ↗ |
| Jan 29, 2026 | Varney Michael David | director | Acquired · Grant / award | 96,000Stock option (right to buy) | — | ↗ |
| Jan 29, 2026 | Garner Ebun | General Counsel & Corp. Sec. | Acquired · Grant / award | 560,000Stock option (right to buy) | — | ↗ |
| Jan 7, 2026 | Garner Ebun | General Counsel & Corp. Sec. | Acquired · Option exercise | 120,000 | $1.70 | ↗ |
| Jan 7, 2026 | Garner Ebun | General Counsel & Corp. Sec. | Disposed · Open-market sale | 120,000 | $5.59 | ↗ |
| Jan 1, 2026 | Bristol James Arthur | director | Acquired · Grant / award | 37,762Stock Option (right to buy) | — | ↗ |
* Holdings as reported for Jun 30, 2026, 140 days old; funds file up to 45 days after each quarter-end, so the newest complete quarter runs 45 to 135 days behind.
** A price of “—” marks an option exercise, RSU vest or a filing without a usable per-share price, not a $0 trade.
Common questions
How much of Erasca do institutions hold?
13F filers reported holding 82.4% of Erasca's shares as of Jun 30, 2026, across 258 filers.
How many 13F filers hold Erasca?
Erasca was held by 258 13F filers as of Jun 30, 2026.
Not investment advice.

